A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer Summary This phase Ib/II trial investigated the efficacy and safety of atezolizumab (an immunotherapy drug) combined Read More
Tags :Predictive markers
Education, Research & Positions
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types Summary Neoadjuvant immunotherapy (NAIT), administering immunotherapy before surgery, is rapidly changing cancer treatment. Early trials show promising results, including higher rates of pathological complete response (Read More
Site Logo
All-Time Views
930K+ and Counting..!
Follow me on Linkedin for Latest Jobs and Scholarships
Join WhatsApp
Click the ICON to Join
Subscribe Youtube
Celebrating 6 Years
Now, it has been 6 years since it was launched in late July 2018 and is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
Site Trust Score
Google Safe
